139 related articles for article (PubMed ID: 7768774)
21. In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens.
Mezzatesta ML; La Rosa G; Maugeri G; Zingali T; Caio C; Novelli A; Stefani S
Int J Antimicrob Agents; 2017 Jun; 49(6):763-766. PubMed ID: 28390962
[TBL] [Abstract][Full Text] [Related]
22. [Antibiotics of the phosphonic acid group].
Poliak MS
Antibiot Med Biotekhnol; 1987 Jan; 32(1):66-75. PubMed ID: 3551820
[No Abstract] [Full Text] [Related]
23. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
[TBL] [Abstract][Full Text] [Related]
24. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
26. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
Inouye S; Watanabe T; Tsuruoka T; Kitasato I
J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
[TBL] [Abstract][Full Text] [Related]
27. Effects of subinhibitory concentrations of fosfomycin on bacteria.
Lorian V; Atkinson B
G Ital Chemioter; 1977; 23(2):65-74. PubMed ID: 342326
[No Abstract] [Full Text] [Related]
28. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
29. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
Ungheri D; Albini E; Belluco G
J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
[TBL] [Abstract][Full Text] [Related]
30. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
McGregor JA; Levin MJ; Masters H
J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
[No Abstract] [Full Text] [Related]
31. In vitro activity of fosfomycin.
Rodriguez A; Olay T; Oliver LE; Vicente MV
G Ital Chemioter; 1977; 23(2):95-103. PubMed ID: 414954
[No Abstract] [Full Text] [Related]
32. [Fosfomycin. I. Antimicrobial action in vitro].
Carlone NA; Cuffini AM; Cattaneo O
G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140
[TBL] [Abstract][Full Text] [Related]
33. Fosfomycin: interpretation of inhibition zones obtained with the Bauer-Kirby agar disk diffusion susceptibility test.
Traub WH; Spohr M
Chemotherapy; 1983; 29(3):208-12. PubMed ID: 6872618
[No Abstract] [Full Text] [Related]
34. Fosfomycin tromethamine: single-dose treatment of acute cystitis.
Stein GE
Int J Fertil Womens Med; 1999; 44(2):104-9. PubMed ID: 10338268
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of fosfomycin in vitro.
Forsgren A; Walder M
J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
[TBL] [Abstract][Full Text] [Related]
37. International collaborative study on standardization of bacterial sensitivity to fosfomycin.
Andrews JM; Baquero F; Beltran JM; Canton E; Crokaert F; Gobernado M; Gomez-Ius R; Loza E; Navarro M; Olay T
J Antimicrob Chemother; 1983 Oct; 12(4):357-61. PubMed ID: 6643331
[TBL] [Abstract][Full Text] [Related]
38. [Antibacterial kinetics of fosfomycin (author's transl)].
Gevaudan MJ; Mallet MN; Charrel J; Dalmas N; Gulian C; Gevaudan P
Ann Biol Clin (Paris); 1979; 37(6):327-30. PubMed ID: 547759
[TBL] [Abstract][Full Text] [Related]
39. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
Kojo H; Shigi Y; Nishida M
J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
[TBL] [Abstract][Full Text] [Related]
40. Fosfomycin: Resurgence of an old companion.
Sastry S; Doi Y
J Infect Chemother; 2016 May; 22(5):273-80. PubMed ID: 26923259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
